• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGM454520J
Device Problems Difficult to Remove (1528); Stretched (1601); Difficult to Advance (2920)
Patient Problems Hemorrhage/Bleeding (1888); Perforation of Vessels (2135); Abdominal Distention (2601)
Event Date 12/25/2023
Event Type  Injury  
Manufacturer Narrative
H3: code "other" was selected as the medical device was discarded at facility.Return not possible.H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The following was reported to gore: on (b)(6), 2023, the patient underwent an endovascular treatment of a distal type i endoleak from a frozen elephant trunk (fet) using non-gore device using gore® tag® conformable thoracic stent graft with active control system.Two gore® tag® conformable thoracic stent grafts with active control system (tgm454520j) were planned to implant from a descending aorta to fet.A 24fr gore® dryseal flex introducer sheath was inserted from the left side and a first gore® tag® conformable thoracic stent graft with active control system was implanted distally.Then a second gore® tag® conformable thoracic stent graft with active control system was attempted to implant proximally, but the catheter of the gore® tag® conformable thoracic stent graft with active control system was not able to be advanced due to tortuous access vessel and aorta.As a reaction to this delivery difficulty, the 24fr sheath was coming out.So, the second gore® tag® conformable thoracic stent graft with active control system was attempted to remove.However, the gore® tag® conformable thoracic stent graft with active control system was not able to be pulled into the 24fr sheath.So, the 24fr sheath was removed and the second gore® tag® conformable thoracic stent graft with active control system was removed without the sheath.When the second gore® tag® conformable thoracic stent graft with active control system was removed, the blood pressure decreased.Therefore, new 24fr gore® dryseal flex introducer sheath was inserted.The angiography revealed the left external iliac artery rupture and the bleeding from the left external iliac artery.This external iliac artery rupture was due to the gore® tag® conformable thoracic stent graft with active control system was removed without the sheath.The removed gore® tag® conformable thoracic stent graft with active control system was observed and there was a gap between the constrained stent graft part and the remaining catheter, it was like the catheter elongation occurred between the constrained stent graft part and the remaining catheter.And it seemed the catheter was not firm and it was hard to maintain the constrained stent graft.This gore® tag® conformable thoracic stent graft with active control system was abandoned to use and another gore® tag® conformable thoracic stent graft with active control system (tgm454515j) was implanted as a replacement.The gore® excluder® aaa endoprosthesis (contralateral leg) was implanted to treat the external iliac artery.A stenosis due to a damage of an intima of the external iliac artery where the distal of the contralateral leg was observed and a stent was implanted to near the canulation site to treat it.The blood flow was well.A damage of an intima of the cannulation site was treated by surgery.The damage of the intima was due to the gore® tag® conformable thoracic stent graft with active control system was removed without the sheath as well.Afterward, an abdominal compartment syndrome (acs) was observed and the blood pressure was not increased.A rupture in the aorta was suspected and an angiography was performed to the aorta.However, the rupture was not able to be confirmed.A laparotomy was performed to reduce the pressure.A transfusion etc.Were performed and the patient vital signs became stable.Then, the patient left the operating room.Reportedly, acs might have been occurred due to the left external iliac rupture because there was no rupture in the aorta.The physician stated that the left external iliac artery rupture was covered using the contralateral leg and the angiography confirmed no bleeding but the bleeding might have remained.The patient condition after the procedure is unknown.
 
Event Description
The following was reported to gore: on (b)(6) 2023, the patient underwent an endovascular treatment of a distal type i endoleak from a frozen elephant trunk (fet) which used a non-gore device.Two gore® tag® conformable thoracic stent grafts with active control system (tgm454520j) were planned to implant from a descending aorta to fet.A 24fr gore® dryseal flex introducer sheath was inserted from the left side and a first gore® tag® conformable thoracic stent graft with active control system was implanted distally.Then a second gore® tag® conformable thoracic stent graft with active control system was attempted to implant proximally, but the catheter of the gore® tag® conformable thoracic stent graft with active control system was not able to be advanced due to tortuous access vessel and aorta.As a reaction to this delivery difficulty, the 24fr sheath was coming out.So, the second gore® tag® conformable thoracic stent graft with active control system was attempted to remove.However, the gore® tag® conformable thoracic stent graft with active control system was not able to be pulled into the 24fr sheath.So, the second gore® tag® conformable thoracic stent graft with active control system and sheath were removed together, with the gore® tag® conformable thoracic stent graft with active control constrained stent graft not within the sheath.When the second gore® tag® conformable thoracic stent graft with active control system was removed, the blood pressure decreased.Therefore, new 24fr gore® dryseal flex introducer sheath was inserted.The angiography revealed the left external iliac artery rupture and the bleeding from the left external iliac artery.This external iliac artery rupture was due to the gore® tag® conformable thoracic stent graft with active control system was removed with not pulling back into the sheath.The removed gore® tag® conformable thoracic stent graft with active control system was observed and there was a gap between the constrained stent graft part and the remaining catheter, it was like the catheter elongation occurred between the constrained stent graft part and the remaining catheter.And it seemed the catheter was not firm and it was hard to maintain the constrained stent graft.This gore® tag® conformable thoracic stent graft with active control system was abandoned to use and another gore® tag® conformable thoracic stent graft with active control system (tgm454515j) was implanted as a replacement.The gore® excluder® aaa endoprosthesis (contralateral leg) was implanted to treat the external iliac artery.A stenosis due to a damage of an intima of the external iliac artery where the distal of the contralateral leg was observed and a stent was implanted to near the canulation site to treat it.The blood flow was well.A damage of an intima of the cannulation site was treated by surgery.The damage of the intima was due to the gore® tag® conformable thoracic stent graft with active control system was removed with not pulling back into the sheath.Afterward, an abdominal compartment syndrome (acs) was observed and the blood pressure was not increased.A rupture in the aorta was suspected and an angiography was performed to the aorta.However, the rupture was not able to be confirmed.A laparotomy was performed to reduce the pressure.A transfusion etc.Were performed and the patient vital signs became stable.Then, the patient left the operating room.Reportedly, acs might have been occurred due to the left external iliac rupture because there was no rupture in the aorta.The physician stated that the left external iliac artery rupture was covered using the contralateral leg and the angiography confirmed no bleeding but the bleeding might have remained.The patient condition after the procedure is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
asami aizawa
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key18515478
MDR Text Key332877231
Report Number2017233-2024-04550
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/16/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberTGM454520J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/19/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age71 YR
Patient SexMale
-
-